Di Nuzzo Private Wealth, Inc. Summit Therapeutics Inc. Call Options Transaction History
Di Nuzzo Private Wealth, Inc.
- $617 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SMMT
# of Institutions
235Shares Held
83.3MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$602 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$288 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$195 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$162 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$138 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.96B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...